News
Acted as Rule 3 Adviser, Financial Adviser, Nominated Adviser and Sole Broker
14th November 2023
Panmure Gordon is delighted to announce that it has acted as Rule 3 Adviser, Financial Adviser, Nominated Adviser and Sole Broker to Allergy Therapeutics…
Read more